Novo Nordisk, Eli Lilly are tackling supply issues
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss …
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss …
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a …
We don’t know what we want. This week, we will find out what it is that will propel us forward or turn us back after the S & P 500 …
Worries over the prospect of elevated interest rates for a longer time horizon linger on investors’ minds, even as stocks reach fresh highs. Nonetheless, analysts remain focused on the bigger …
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason …
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk …
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from …
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s …
Former Vice President Al Gore speaks during the Agriculture Innovation Mission (AIM) for Climate Summit at the JW Marriott on May 08, 2023 in Washington, DC. Chip Somodevilla | Getty …
CNBC’s Jim Cramer on Tuesday shared what he learned from his two days at JPMorgan‘s health-care conference. He marveled at the myriad of uses for generative artificial intelligence in health …